fulvestrant has been researched along with Alopecia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Buisseret, L; de Azambuja, E; Eiger, D; Nogueira, MS; Pondé, NF; Wagner, M | 1 |
Handjiski, B; Ohnemus, U; Paus, R; Unalan, M | 1 |
Frank, LA | 1 |
Gassmueller, J; Hoffmann, R; Webster, A | 1 |
1 review(s) available for fulvestrant and Alopecia
Article | Year |
---|---|
The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC).
Topics: Alopecia; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Breast Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Estrogen Receptor alpha; Female; Fulvestrant; Germany; Humans; Incidence; Neoplasm Metastasis; Piperazines; Protein Kinase Inhibitors; Purines; Pyridines; Quality of Life; Randomized Controlled Trials as Topic; Receptors, Progesterone; Survival Rate; Tamoxifen | 2020 |
2 trial(s) available for fulvestrant and Alopecia
Article | Year |
---|---|
Oestrogen receptor antagonist and hair regrowth in dogs with hair cycle arrest (alopecia X).
Topics: Alopecia; Animals; Dog Diseases; Dogs; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hair Follicle; Injections, Intramuscular; Male; Severity of Illness Index; Treatment Outcome | 2007 |
Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
Topics: Administration, Topical; Adolescent; Adult; Aged; Alopecia; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hair; Humans; Male; Middle Aged; Minoxidil; Severity of Illness Index; Treatment Outcome; Vasodilator Agents | 2008 |
1 other study(ies) available for fulvestrant and Alopecia
Article | Year |
---|---|
Topical estrogen accelerates hair regrowth in mice after chemotherapy-induced alopecia by favoring the dystrophic catagen response pathway to damage.
Topics: Administration, Topical; Alopecia; Animals; Antineoplastic Agents, Alkylating; Cyclophosphamide; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hair; Mice; Mice, Inbred C57BL | 2004 |